Cargando…
Proton pump inhibitor-induced subacute cutaneous lupus erythematosus
SUMMARY: BACKGROUND: Drug-induced subacute cutaneous lupus erythematosus (SCLE) has been known in the literature since 1985 and is increasingly recognized. OBJECTIVES: To identify and describe patients with proton pump inhibitor (PPI)-induced SCLE. METHODS: A retrospective medical chart review of pa...
Autores principales: | Sandholdt, LH, Laurinaviciene, R, Bygum, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232902/ https://www.ncbi.nlm.nih.gov/pubmed/24547721 http://dx.doi.org/10.1111/bjd.12699 |
Ejemplares similares
-
Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors
por: Aggarwal, Nitish
Publicado: (2016) -
Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: case report and literature review
por: Reich, Adam, et al.
Publicado: (2012) -
Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature
por: Kaur, Sukhjot, et al.
Publicado: (2022) -
Capecitabine-induced Subacute Cutaneous Lupus Erythematosus()()
por: Rocha, Aroni, et al.
Publicado: (2019) -
Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)